Syngene Q3 Review: Revenue Up By 11% (YoY); What's In Store For FY25? | NDTV Profit

Syngene is a contract research, development and manufacturing company. It recently posted its Q3 earnings, with revenue up by 11% (YoY) at ₹943.7 cr. But the stock tanked nearly 6% in today's trade after the earnings were revealed. Here's Jonathan Hunt, MD & CEO of Syngene International sharing his views on the company's Q3 earnings. Listen in.
#syngene #syngeneshare #syngeneresults
-------------------------------------------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: / @ndtvprofitindia
Visit NDTV Profit for more news: www.ndtvprofit...
Don't enter the stock market unaware. Read all Research Reports here: www.ndtvprofit...
Follow NDTV Profit here
Twitter: / ndtvprofitindia , / ndtvprofit
LinkedIn: / ndtvprofit
Instagram: / ndtvprofit
Facebook: / ndtvprofit